November 21st 2024
Coverage from the recent Institute for Value-Based Medicine event with NYU Langone Health.
November 20th 2024
Emotional Improvement Seen Among T1D Patients Using CLC Systems
May 24th 2022The authors of this study evaluated outcomes among children aged 7 to 16 years, all living with type 1 diabetes (T1D), who attended a 3-day virtual education camp that focused on their use of a closed-loop control (CLC) system for insulin delivery.
Read More
Use of AI in Gastroenterology Can Move Beyond “Cool Tools” to Improve Practice Efficiency
May 21st 2022As artificial intelligence (AI) technology in the gastrointestinal field continues to advance, speakers at Digestive Disease Week 2022 discussed how these tools can be put into practice to improve efficiency, reduce physician burnout, and reap cost savings.
Read More
Superior T1D Control Seen With HCL Systems vs SAP Therapy in Older Adults
May 15th 2022Type 1 diabetes (T1D) can be especially difficult to manage in older adults, so this new multinational review compared the safety and effectiveness of a hybrid closed-loop (HCL) system and sensor-augmented pump (SAP) therapy.
Read More
HCL Systems Convey Superior Glucose Outcomes vs Other Diabetes Technologies
May 11th 2022This new study among a patient population living with type 1 diabetes compared their outcomes according to their type of insulin pump therapy: sensor-augmented pump, predictive low-glucose suspend, and hybrid closed-loop (HCL).
Read More
What's Behind Lagging Payer Uptake of Prescription Digital Therapeutics?
May 10th 2022In a session at the 2022 Asembia Specialty Pharmacy Summit, Jayne Hornung, chief clinical officer at Managed Markets Insights & Technology (MMIT), outlined factors driving payer hesitation when it comes to covering prescription digital therapeutics.
Read More
Remote Monitoring Not Successful at Reducing Death, Readmission From HF
May 9th 2022In this study, investigators from Pennsylvania and New York evaluated outcomes among patients following their hospitalization for heart failure (HF) who did or did not participate in a remote monitoring program that included financial incentives for adherence.
Read More
SES-Related Insulin Pump Uptake Disparities Seen in 2 Canadian Provinces
May 4th 2022Using socioeconomic status (SES) as their primary exposure, investigators from McGill University, University of Manitoba, Institut National de Santé Publique du Québec, and Laval University investigated reasons behind insulin pump uptake disparities in the Canadian provinces of Manitoba and Québec.
Read More
Novel Internet-Based Hospital-to-Home Model for Nutritional Nursing Effective in Patients With CKD
April 23rd 2022Continual nutrition modification is crucial in patients with moderate to advanced chronic kidney disease (CKD), and more interactive at-home solutions hold potential to improve nutritional nursing models after hospital discharge.
Read More
Experts Explore the Potential of Wearable Tech in T1D Management
April 15th 2022This new literature review explored the potential to enhance management for type 1 diabetes (T1D) through the adoption of physiological parameters measured by wearable and sensor-enabled health-related technology.
Read More
Higher DKA Rates Seen in Black Patients With T1D Throughout COVID-19
April 7th 2022Compared with other racial/ethnic groups, Black patients with type 1 diabetes (T1D) presented to medical centers with diabetic ketoacidosis (DKA) more often throughout the COVID-19 pandemic, regardless of COVID-19 infection.
Read More
Dr Dipti Itchhaporia Highlights Aspects of Virtual Care Here to Stay
April 4th 2022Even as virtual care has dropped from the peaks at the beginning of the pandemic, some aspects of it will not go away in cardiology care, said Dipti Itchhaporia, MD, FACC, the 70th president of the American College of Cardiology.
Watch
Neutral Findings Predominate German Study of CGM Use
March 22nd 2022This new study from Germany evaluated the use of and satisfaction with continuous glucose monitors (CGMs) since health insurance companies in the country began reimbursement of the technology in 2016 for persons with insulin-dependent diabetes.
Read More